InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Discover the detailed record of transactions filed by Wedell-Wedellsborg Johan, Director. Director active across 1 companies, notably Y-mAbs Therapeutics, Inc.. In total, 10 disclosures have been recorded. Total volume traded: €9.8m. The latest transaction was disclosed on 10 June 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
€333,51311,229 shares@ €29.70113.4% of flow
Common Stock
SEC:0001104659-21-080236:0·
€333,51311,229 shares@ €29.70116.8% of flow
Common Stock
SEC:0001104659-21-080236·
€965,01133,300 shares@ €28.979319.7% of flow
Common Stock
SEC:0001104659-21-079592·
€965,01133,300 shares@ €28.97939.8% of flow
Common Stock
SEC:0001104659-21-079592:0·
€2m72,400 shares@ €28.007820.6% of flow
Common Stock
SEC:0001104659-21-078949:0·
€2m72,400 shares@ €28.007841.3% of flow
Common Stock
SEC:0001104659-21-078949·
€838,76130,666 shares@ €27.351517.1% of flow
Common Stock
SEC:0001104659-21-077703·
€838,76130,666 shares@ €27.35158.5% of flow
Common Stock
SEC:0001104659-21-077703:0·
€745,06825,000 shares@ €29.802715.2% of flow
Common Stock
SEC:0001104659-21-075782·
€745,06825,000 shares@ €29.80277.6% of flow
Common Stock
SEC:0001104659-21-075782:0·
10 of 10 declarations
About Wedell-Wedellsborg Johan
Johan Wedell-Wedellsborg is a Director at Y-mAbs Therapeutics, Inc. He plays a key role in overseeing the company's activities and strategic direction. His expertise in the biotechnology field allows him to contribute to the innovation and growth of the company.
